ARCHIVES

Phase II Study Tests Chemo Plus Mylotarg For AML

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of December

December 27, 2013

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

AHRQ Funds Research To Reduce Medical Errors.

October 19, 2001

Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions.

May 19, 2006